JP2017535756A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017535756A5 JP2017535756A5 JP2017516994A JP2017516994A JP2017535756A5 JP 2017535756 A5 JP2017535756 A5 JP 2017535756A5 JP 2017516994 A JP2017516994 A JP 2017516994A JP 2017516994 A JP2017516994 A JP 2017516994A JP 2017535756 A5 JP2017535756 A5 JP 2017535756A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- small molecule
- acid
- compared
- control sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20145855 | 2014-10-02 | ||
| FI20145855 | 2014-10-02 | ||
| PCT/FI2015/050654 WO2016051020A1 (en) | 2014-10-02 | 2015-10-02 | Methods for detecting ovarian cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017535756A JP2017535756A (ja) | 2017-11-30 |
| JP2017535756A5 true JP2017535756A5 (cg-RX-API-DMAC7.html) | 2018-11-29 |
| JP6892820B2 JP6892820B2 (ja) | 2021-06-23 |
Family
ID=55629471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017516994A Active JP6892820B2 (ja) | 2014-10-02 | 2015-10-02 | 卵巣癌を検出する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10534001B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3201623B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6892820B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20170061704A (cg-RX-API-DMAC7.html) |
| CN (1) | CN106716127B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015326756A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112017006593A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2959832A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201701875YA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016051020A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3351938A1 (en) * | 2017-01-18 | 2018-07-25 | BIOCRATES Life Sciences AG | New biomarkers for assessing ovarian cancer |
| WO2019008009A1 (en) | 2017-07-05 | 2019-01-10 | Zora Biosciences Oy | METHODS OF DETECTING OVARIAN CANCER |
| CN107656006A (zh) * | 2017-09-08 | 2018-02-02 | 上海市东方医院 | 用于检测血清或者血浆中α‑羟基丁酸浓度的试剂盒和方法 |
| CN108152430A (zh) * | 2017-12-21 | 2018-06-12 | 上海中科新生命生物科技有限公司 | 基于prm检测的卵巢癌标志物检测试剂盒及检测方法 |
| WO2020160108A1 (en) * | 2019-01-30 | 2020-08-06 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Lipid biomarkers for cancer screening and monitoring |
| CN111430030A (zh) * | 2020-04-17 | 2020-07-17 | 武汉大学 | 生物标志物在卵巢癌评估中的应用方法及系统 |
| CN114544848B (zh) * | 2020-11-25 | 2023-04-28 | 中国科学院大连化学物理研究所 | 一种用于诊断卵巢上皮癌的血清脂质标志物组合物及试剂盒和其与应用 |
| EP4246146A1 (en) * | 2022-03-14 | 2023-09-20 | Fundació Institut Mar d'Investigacions Mèdiques (IMIM) | Method for diagnosing cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824555A (en) | 1996-05-30 | 1998-10-20 | The Cleveland Clinic Foundation | Method of detecting gynecological carcinomas |
| US20050054942A1 (en) * | 2002-01-22 | 2005-03-10 | Melker Richard J. | System and method for therapeutic drug monitoring |
| US20030180953A1 (en) * | 2000-12-29 | 2003-09-25 | Elitra Pharmaceuticals, Inc. | Gene disruption methodologies for drug target discovery |
| US20040199819A1 (en) * | 2001-08-10 | 2004-10-07 | Jorg Dauerer | Method for fast and local error correction in the event of the failure of individual physical corrections in bundled communication connections and communication system device for carrying out the method |
| US20040180387A1 (en) * | 2003-03-13 | 2004-09-16 | Fujirebio Diagnostics, Inc. | Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| US20050170441A1 (en) | 2003-09-12 | 2005-08-04 | Health Research, Inc. | Early detection of cancer of specific type using 1HNMR metabonomics |
| WO2009052186A1 (en) * | 2007-10-15 | 2009-04-23 | Georgia Tech Research Corporation | Metabolomics-based identification of disease-causing agents |
| US9213030B2 (en) | 2008-01-28 | 2015-12-15 | National University Of Singapore | Lipid tumour profile |
| WO2009151967A1 (en) | 2008-05-28 | 2009-12-17 | Georgia Tech Research Corporation | Metabolic biomarkers for ovarian cancer and methods of use thereof |
| JP4744618B2 (ja) * | 2009-04-13 | 2011-08-10 | シャープ株式会社 | ガス成分検出装置 |
| KR20120011042A (ko) * | 2009-04-15 | 2012-02-06 | 샌포드-번햄 메디칼 리서치 인스티튜트 | 항아폽토시스 단백질의 나프탈렌계 억제제 |
| EP2513653A1 (en) * | 2009-10-09 | 2012-10-24 | Carolyn Slupsky | Methods for diagnosis, treatment and monitoring of patient health using metabolomics |
| US20110114511A1 (en) * | 2009-11-17 | 2011-05-19 | Sjong Angele | Apparatus for detecting volatile organic compounds and related methods |
| GB201016139D0 (en) | 2010-09-24 | 2010-11-10 | Univ Leuven Kath | Cancer phosholipidome |
| FI20115576A0 (fi) * | 2011-06-10 | 2011-06-10 | Teknologian Tutkimuskeskus Vtt Oy | Menetelmä Alzheimerin taudin diagnoimiseksi |
| US20140156573A1 (en) | 2011-07-27 | 2014-06-05 | The Research Foundation Of State University Of New York | Methods for generating predictive models for epithelial ovarian cancer and methods for identifying eoc |
-
2015
- 2015-10-02 CN CN201580052938.0A patent/CN106716127B/zh active Active
- 2015-10-02 SG SG11201701875YA patent/SG11201701875YA/en unknown
- 2015-10-02 US US15/513,755 patent/US10534001B2/en active Active
- 2015-10-02 BR BR112017006593A patent/BR112017006593A2/pt not_active Application Discontinuation
- 2015-10-02 CA CA2959832A patent/CA2959832A1/en not_active Abandoned
- 2015-10-02 AU AU2015326756A patent/AU2015326756A1/en not_active Abandoned
- 2015-10-02 WO PCT/FI2015/050654 patent/WO2016051020A1/en not_active Ceased
- 2015-10-02 KR KR1020177011691A patent/KR20170061704A/ko not_active Withdrawn
- 2015-10-02 JP JP2017516994A patent/JP6892820B2/ja active Active
- 2015-10-02 EP EP15846140.0A patent/EP3201623B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017535756A5 (cg-RX-API-DMAC7.html) | ||
| Jung et al. | Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling | |
| EP2577314B1 (en) | Means and methods for diagnosing pancreatic cancer in a subject | |
| Wang et al. | The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics | |
| Liu et al. | LC-MS-based plasma metabolomics and lipidomics analyses for differential diagnosis of bladder cancer and renal cell carcinoma | |
| Baranyi et al. | Nitric oxide-related biological pathways in patients with major depression | |
| AU2012343843B2 (en) | Device and methods to diagnose pancreatic cancer | |
| Crotti et al. | Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker | |
| EP2580596B1 (en) | Methods to diagnose liver diseases | |
| EP2804001B1 (en) | Methods for diagnosing prostate carcinomas | |
| EP3084443B1 (en) | Means and methods for diagnosing pancreatic cancer in a subject based on a metabolite panel | |
| Monteiro et al. | Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma | |
| Liesenfeld et al. | Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare) | |
| EP3317671B1 (en) | Use of cell-free nucleosomes as biomarkers in sputum samples | |
| Pu et al. | Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA | |
| AU2010326737A1 (en) | Means and methods for diagnosing multiple sclerosis | |
| Lee et al. | Targeted metabolomic biomarkers for stroke subtyping | |
| Zhang et al. | High Sam68 expression predicts poor prognosis in non-small cell lung cancer | |
| Yoo et al. | Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis | |
| Velenosi et al. | Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer | |
| Yang et al. | Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis | |
| EP2904397B1 (en) | Means and methods for diagnosing recurrence of prostate cancer after prostatectomy | |
| Meng et al. | Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach | |
| Chen et al. | Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variability | |
| Kumar et al. | Metabolomics of prostate cancer: Knock-in versus knock-out prostate |